Senescent Cancer Cells in Immune Surveillance and Evasion: Mechanisms and Therapeutic Implications
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cellular senescence, a state of irreversible cell cycle arrest, has a dual role in cancer immunity. Senescent cancer cells (SnCs) can promote or suppress anti-tumor immune responses, impacting cancer progression.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- Cellular senescence is a stress-induced state characterized by cell cycle arrest and the secretion of bioactive molecules (SASP).
- Senescent cancer cells (SnCs) can influence the tumor microenvironment (TME) by modulating immune responses.
- The dual role of SnCs in promoting anti-tumor immunity versus immune suppression requires detailed understanding.
Purpose Of The Study
- To review the mechanisms by which the immune system recognizes and eliminates SnCs.
- To explore how SnCs evade immune surveillance within the TME.
- To discuss novel cancer treatment strategies targeting SnCs.
Main Methods
- Literature review of cellular senescence and cancer immunology.
- Analysis of immune recognition and evasion mechanisms by SnCs.
- Exploration of therapeutic strategies including SnC-based vaccines and combination therapies.
Main Results
- The immune system employs three primary mechanisms to recognize and eliminate SnCs.
- SnCs utilize three distinct strategies to evade immune surveillance in the TME.
- Emerging therapeutic approaches leverage SnCs for cancer treatment.
Conclusions
- Understanding SnC-immune interactions is crucial for cancer therapy development.
- Targeting SnCs offers potential for enhancing anti-tumor immunity.
- Novel strategies like SnC-based vaccines and combination therapies show promise.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.